BR0113987A - Composto heteromático bicìclico, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de derivados heteroaromáticos bicìclicos ou de um sal ou solvato farmaceuticamente aceitável dos mesmos - Google Patents

Composto heteromático bicìclico, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de derivados heteroaromáticos bicìclicos ou de um sal ou solvato farmaceuticamente aceitável dos mesmos

Info

Publication number
BR0113987A
BR0113987A BR0113987-8A BR0113987A BR0113987A BR 0113987 A BR0113987 A BR 0113987A BR 0113987 A BR0113987 A BR 0113987A BR 0113987 A BR0113987 A BR 0113987A
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
acceptable salt
bicyclic
compound
pharmaceutical composition
Prior art date
Application number
BR0113987-8A
Other languages
English (en)
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0113987A publication Critical patent/BR0113987A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTO HETEROMáTICO BICìCLICO, OU UM SAL FARMACEUTICAMENTE ACEITáVEL DO MESMO, COMPOSIçãO FARMACêUTICA, E, USO DE DERIVADOS HETEROAROMáTICOS BICìCLICOS OU DE UM SAL OU SOLVATO FARMACEUTICAMENTE ACEITáVEL DOS MESMOS". Um composto heteroaromático bicíclico de acordo com a fórmula geral (I) ou um sal farmaceuticamente aceitável do mesmo, em que R^ 1^ é cicloalquila (C3-8), heterocicloalquila (C2-7), arila (C6-14) ou heteroarila (C4-13); todos opcionalmente substituídos com um ou mais substituintes; R^ 2^ é alquila (C1-4), alquenila (C2-4), alquinila (C2-4), arila (C6-14), ou heteroarila (C4-13); R^ 3^ é alquila (C1-8), cicloalquila (C3-8), heterocicloalquila (C2-7), arila (C6-14) ou heteroarila (C4-13); Y é CH ou N; Z é NH~ 2~ ou OH; A é S, N(H), N(R), O ou uma ligação e B é (NH), O ou uma ligação; X1-X2 é C=C, C(O)-NH, NH-C(O), C (O)-O, OC(O), C=N, N=C ou S ou O. Os compostos da invenção podem ser usados em terapia de regulação da fertilidade.
BR0113987-8A 2000-09-22 2001-09-17 Composto heteromático bicìclico, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de derivados heteroaromáticos bicìclicos ou de um sal ou solvato farmaceuticamente aceitável dos mesmos BR0113987A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (1)

Publication Number Publication Date
BR0113987A true BR0113987A (pt) 2003-08-12

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113987-8A BR0113987A (pt) 2000-09-22 2001-09-17 Composto heteromático bicìclico, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de derivados heteroaromáticos bicìclicos ou de um sal ou solvato farmaceuticamente aceitável dos mesmos

Country Status (32)

Country Link
US (2) US7229990B2 (pt)
EP (2) EP1886999A3 (pt)
JP (1) JP4977940B2 (pt)
KR (1) KR100860040B1 (pt)
CN (1) CN1247594C (pt)
AR (1) AR030784A1 (pt)
AT (1) ATE384726T1 (pt)
AU (2) AU2002213929B2 (pt)
BR (1) BR0113987A (pt)
CA (1) CA2422054C (pt)
CY (1) CY1107308T1 (pt)
CZ (1) CZ297136B6 (pt)
DE (1) DE60132607T2 (pt)
DK (1) DK1322651T3 (pt)
EC (1) ECSP034523A (pt)
ES (1) ES2299524T3 (pt)
HK (1) HK1054942A1 (pt)
HR (1) HRP20030220B1 (pt)
HU (1) HU229422B1 (pt)
IL (2) IL154624A0 (pt)
IS (1) IS2531B (pt)
MX (1) MXPA03002478A (pt)
NO (1) NO328683B1 (pt)
NZ (1) NZ524444A (pt)
PE (1) PE20020537A1 (pt)
PL (1) PL207755B1 (pt)
PT (1) PT1322651E (pt)
RU (1) RU2271360C2 (pt)
SK (1) SK287554B6 (pt)
TW (1) TWI290143B (pt)
WO (1) WO2002024703A1 (pt)
ZA (1) ZA200301588B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247594C (zh) * 2000-09-22 2006-03-29 阿克佐诺贝尔公司 二环杂芳族化合物
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
CA2608405A1 (en) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2007136776A2 (en) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
WO2009132980A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag Pyrimidinyl pyridone inhibitors of jnk.
JP5718233B2 (ja) 2008-10-20 2015-05-13 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 甲状腺刺激ホルモン受容体（ｔｓｈｒ）の低分子量アゴニスト
EP2563777A4 (en) 2010-04-08 2013-09-04 Us Health INVERSE AGONISTS AND NEUTRAL AGONISTS FOR THE TSH RECEPTOR
CN108707151B (zh) * 2011-08-23 2022-06-03 阿萨纳生物科技有限责任公司 嘧啶并-哒嗪酮化合物及其用途
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL181895B1 (pl) * 1994-06-16 2001-10-31 Pfizer Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL
AU712019B2 (en) * 1996-05-20 1999-10-28 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
CN1247594C (zh) * 2000-09-22 2006-03-29 阿克佐诺贝尔公司 二环杂芳族化合物

Also Published As

Publication number Publication date
WO2002024703A1 (en) 2002-03-28
NZ524444A (en) 2004-03-26
CN1247594C (zh) 2006-03-29
EP1322651B1 (en) 2008-01-23
CZ2003828A3 (cs) 2003-08-13
CA2422054C (en) 2011-01-11
JP4977940B2 (ja) 2012-07-18
ZA200301588B (en) 2004-06-22
US7618963B2 (en) 2009-11-17
IS6732A (is) 2003-02-28
PL207755B1 (pl) 2011-01-31
US20070197527A1 (en) 2007-08-23
NO20031314L (no) 2003-03-21
SK287554B6 (sk) 2011-01-04
PT1322651E (pt) 2008-02-28
ECSP034523A (es) 2003-04-25
PE20020537A1 (es) 2002-06-20
IS2531B (is) 2009-07-15
EP1322651A1 (en) 2003-07-02
DE60132607D1 (de) 2008-03-13
DK1322651T3 (da) 2008-06-02
EP1886999A2 (en) 2008-02-13
CA2422054A1 (en) 2002-03-28
US20030225113A1 (en) 2003-12-04
NO20031314D0 (no) 2003-03-21
ATE384726T1 (de) 2008-02-15
JP2004509896A (ja) 2004-04-02
IL154624A (en) 2009-09-01
IL154624A0 (en) 2003-09-17
PL360675A1 (en) 2004-09-20
HRP20030220B1 (en) 2011-10-31
US7229990B2 (en) 2007-06-12
CZ297136B6 (cs) 2006-09-13
RU2271360C2 (ru) 2006-03-10
ES2299524T3 (es) 2008-06-01
KR20030040483A (ko) 2003-05-22
CY1107308T1 (el) 2012-11-21
HU229422B1 (hu) 2013-12-30
NO328683B1 (no) 2010-04-26
CN1462273A (zh) 2003-12-17
SK3312003A3 (en) 2003-08-05
EP1886999A3 (en) 2008-03-12
AR030784A1 (es) 2003-09-03
HRP20030220A2 (en) 2003-06-30
AU2002213929B2 (en) 2006-04-13
MXPA03002478A (es) 2004-05-05
TWI290143B (en) 2007-11-21
HUP0302648A2 (hu) 2003-11-28
DE60132607T2 (de) 2009-01-29
HK1054942A1 (en) 2003-12-19
KR100860040B1 (ko) 2008-09-25
EP1886999A8 (en) 2010-08-04
HUP0302648A3 (en) 2004-11-29
AU1392902A (en) 2002-04-02

Similar Documents

Publication Publication Date Title
BR0113987A (pt) Composto heteromático bicìclico, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de derivados heteroaromáticos bicìclicos ou de um sal ou solvato farmaceuticamente aceitável dos mesmos
HUP0202501A2 (hu) Pirimidin-2,4,6-trion metalloproteináz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BR9914451A (pt) Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
FI863652A (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BR0009558A (pt) Composto derivado bicìclico heteroaromático, composição farmacêutica, e, uso de compostos derivados bicìclicos heteroaromáticos
BR0314761A (pt) Composto de adenina e seu uso
BR9806413A (pt) Composto e uso do mesmo
AR063555A1 (es) Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
BR0210297A (pt) Derivados de n-arilfenilacetamida e composição farmacêutcia contendo os mesmos
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2114931T3 (es) Nuevos esteres esteroidales.
BR0110955A (pt) Derivados de tropano úteis para a terapia
MX9307946A (es) Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso.
SE9904508D0 (sv) New compounds
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
AR051889A1 (es) Sulfonas de tripeptido y tetrapeptido
BR9911274A (pt) Derivados da artemisinina, seus processos de preparação e as composições farmacêuticas que os contêm
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
BRPI0518560A2 (pt) composto antitrombàtico, composiÇço farmacÊutica, processo para a preparaÇço do composto e uso do composto
BR9813602A (pt) Composições farmacêuticas contendo medicamentos bicìclicos micronizados
AU588562B2 (en) Dopamine-beta-hydroxylase inhibitors
BR0213325A (pt) Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìda para a redução de dano isquêmico

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: MSD OSS B.V. (NL)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V. (NL)

B25A Requested transfer of rights approved

Owner name: MERCK SHARP AND DOHME B.V. (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 15A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.